XBiotech (XBIT) Stock: Buy, Sell, or Hold?
XBIT - XBiotech Inc
$1.93
-0.04 (-2.03%)
▼
5d:
-8.96%
30d:
-10.65%
90d:
-14.6%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 11, 2026
17d
Get Alerted When XBIT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: XBIT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: XBIT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: XBIT is currently trading at $1.93, which is considered oversold relative to its 30-day fair value range of $2.06 to $2.23.
Technical Outlook: Technically, XBIT is in a downtrend. Immediate support is located at $1.86, while resistance sits at $2.33.
Market Sentiment: XBIT scores 17/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $18.00 (+832.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XBIT is in a downtrend. Immediate support is located at $1.86, while resistance sits at $2.33.
Market Sentiment: XBIT scores 17/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $18.00 (+832.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.06 -
$2.23
Company Quality Score
38/100
(SELL)
Options IV Signal
41th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 41th percentile)
- BEARISH: Weak technical setup (17/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 832.6% below Wall St target ($18.00)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.06 -
$2.23
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.31
(16.1%)
Support & Resistance Levels
Support Level
$1.86
Resistance Level
$2.33
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Wall Street Target
$18.00
(+832.6%)
Revenue Growth (YoY)
-93.3%
Share & Embed Analysis
Last updated: October 24, 2026 8:23 AM ET
Data refreshes hourly during market hours. Next update: 9:23 AM
Data refreshes hourly during market hours. Next update: 9:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XBIT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
25 analysts |
$1153 | 52 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 49 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 47 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
17 analysts |
$141 | 52 HOLD |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$117 | 53 HOLD |
